Current and future management of serious skin and skin-structure infections

American Journal of Medicine

Volumn 100, Issue 6 A, 1996, Pages 90S-95S

  Schwartz, Robert ^a,c   Das Young, Leena R ^a   Ramirez Ronda, Carlos ^b   Frank, Elliot ^c  

^a Infectious Diseases and Research   (United States)

^b VA MEDICAL CENTER   (Puerto Rico)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

CEFEPIME; CEFTAZIDIME; CEPHALOSPORIN DERIVATIVE;

ADULT; ANTIBIOTIC THERAPY; BACTERIAL SKIN DISEASE; BACTERIUM ISOLATION; CELLULITIS; CLINICAL TRIAL; CONFERENCE PAPER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COUGHING; EDEMA; ENTEROBACTERIACEAE; FEMALE; GASTROINTESTINAL SYMPTOM; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; RANDOMIZED CONTROLLED TRIAL; RASH; SKIN ABSCESS; SKIN ULCER; STAPHYLOCOCCUS AUREUS; WOUND INFECTION; ARTICLE; BACTERIUM; COMPARATIVE STUDY; DRUG EFFECT; INTRAVENOUS DRUG ADMINISTRATION; ISOLATION AND PURIFICATION; MICROBIOLOGICAL EXAMINATION; MICROBIOLOGY; MIDDLE AGED; SKIN DISEASE; STATISTICS;

BACTERIA; CEFTAZIDIME; CEPHALOSPORINS; FEMALE; HUMANS; INFUSIONS, INTRAVENOUS; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; SKIN DISEASES; SKIN DISEASES, BACTERIAL;

EID: 0030600065     PISSN: 00029343     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0002-9343(96)00111-8     Document Type: Conference Paper

References (8)

1. Swartz MN. Cellulitis and subcutaneous tissue infections. In: Mandell GL, Douglas RG Jr, Bennett JE, eds. Principles and Practice of Infectious Diseases, 4th ed. New York: Churchill Livingstone, 1995:909-929.
2. Kessler RE, Bies M, Buck RE, et al. Comparison of a new cephalosporin, BMY 28142, with other broad-spectrum β-lactam antibiotics. Antimicrob Agents Chemother. 1985;27:207-216.
3. Fung-Tomc J, Dougherty T, DeOrio F, Simich-Jacobson V, and Kessler RE. Activity of cefepime against ceftazidime- and cefotaxime-resistant gram-negative bacteria and its relationship to β-lactamase levels. Antimicrob Agents Chemother. 1989;33:498-502.
4. Oster S, Edelstein H, Cassano K, McCabe R. Open trial of cefepime (BMY 28142) for infections in hospitalized patients. Antimicrob Agents Chemother. 1990;34:954-957.
5. Giamarellou H. Low-dosage cefepime as treatment for serious bacterial infections. J Antimicrob Chemother. 1993;32(suppl B):123-132.
6. Jaurequi L, Matzke D, Scott M, Minns P, Hageage G. Cefepime as treatment for osteomyelitis and other bacterial infections. J Antimicrob Chemother. 1993;32(suppl B):141-149.
7. Mouton Y, Chidiac C, Humbert G, et al. A non-comparative, multicentre study of cefepime in the treatment of serious bacterial infections. J Antimicrob Chemother. 1993;32(suppl B):133-140.
8. Hoepelman A, Kieft H, Aoun M, et al. International comparative study of cefepime and ceftazidime in the treatment of serious bacterial infections. J Antimicrob Chemother. 1993;32(suppl B):175-186.